TSE:4554Pharmaceuticals
Fuji Pharma (TSE:4554) Margin Compression Challenges Bullish Earnings Growth Narrative In Q2 2026
Fuji Pharma (TSE:4554) has reported Q2 2026 revenue of ¥13.8b and basic EPS of ¥15.47, with trailing twelve month revenue at ¥57.3b and EPS at ¥98.53 framing the latest quarter against a full year of earnings power. Over recent periods, the company has seen quarterly revenue range from ¥11.1b in Q2 2025 to ¥15.9b in Q1 2026, while basic EPS has moved between ¥12.12 and ¥47.86, giving investors a broad earnings band to measure against the current share price of ¥2,012. With trailing net profit...